Parvovirus B19 infection of bone marrow in systemic sclerosis patients

Clinical and Experimental Rheumatology

Volumn 17, Issue 6, 1999, Pages 718-720

  Ferri, Clodoveo ^a   Zakrzewska, K ^b   Longombardo, G ^b   Giuggioli, D ^b   Storino, F A A ^b   Pasero, G ^b   Azzi, A ^b  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

Bone marrow; Parvovirus B19; Scleroderma; Systemic sclerosis

Indexed keywords

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BONE MARROW BIOPSY; BONE MARROW DISEASE; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; FIBROBLAST; HUMAN; MALE; MICROVASCULATURE; PARVOVIRUS; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; VIREMIA; VIRUS INFECTION;

ADULT; AGED; ANTIBODIES, VIRAL; BONE MARROW; BONE MARROW DISEASES; DNA, VIRAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; ITALY; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; SCLERODERMA, SYSTEMIC;

EID: 0032719223     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. MEDSGER TA JR.: Systemic sclerosis (scleroderma), localized forms of scleroderma, and calcinosis. In MCCARTY DJ (Ed.): Arthritis and Allied Conditions. 12th edition. Philadelphia, Lea & Febiger, 1992; 1253-92.
2. WHITE B: Immunopathogenesis of systemic sclerosis. Rheum Dis Clin North Am 1996; 22: 695-708.
3. NAIDES SJ: Rheumatic manifestations of parvovirus B19 infection. Rheum Dis Clin North Am 1998; 24: 375-401.
4. FERRI C, LONGOMBARDO G, AZZI A, ZAKRZEWSKA K: Parvovirus B19 and systemic sclerosis. Clin Exp Rheumatol 1999; 17: 267.
5. YOTO Y, KUDOH T, HASEYAMA K et al.: Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol 1995; 91: 1017-8.
6. BROWN KE, ANDERSON SM, YOUNG NS: Erythrocyte P antigen-cellular receptor for B19 virus. Science 1993; 262: 114-7.
7. MASIAT, RODNAN GP, MEDSGER TA JR, et al.: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
8. FERRI C, BERNINI L, CECCHETTI R, et al.: Cutaneous and serological subsets of systemic sclerosis. J Rheumatol 1991; 18: 1826-32.
9. VON POBLOTZKI A, HEMAUER A, GIGLER A, et al.: Antibodies to the non-structural protein of parvovirus B19 in persistently infected patients: Implications for pathogenesis. J Infect Dis 1995; 172: 1356-9.
10. DURIGAN EL, ERDMAN DD, GARY W, PALLANSCH MA, TOROK TJ, ANDERSON LJ: Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods 1993; 44: 155-65.
11. GAREUS R, GIGLER A, HEMAUER A et al.: Characterisation of cis-acting and NS1 protein responsive elements in the P6 promoter of parvovirus B19. J Virol 1998; 72: 609-16.
12. FOTO F, SAAG KG, HOWARD EJ et al.: Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: Evidence for B19 virus persistence. J Infect Dis 1993; 167: 744-8.
13. TAKAHASHI Y, MURAI C, SHIBATA S, et al.: Human parvovirus B19 as causative agent for rheumatoid arthritis. Proc Natl Acad USA 1998; 95: 8227-32.
14. TRAPANI S, ERMINI M, FALCINI F: Human parvovirus B19 infection: Its relationship with systemic lupus erythematosus. Semin Arthritis Rheum 1999; 28: 319-25.
15. GABRIEL SE, ESPY M, ERDMAN DD, BJORNSSON J, SMITH TF, HUNDER GG: The role of parvovirus B19 in the pathogenesis of giant cell arteritis: A preliminary evaluation. Arthritis Rheum 1999; 42: 1255-58.
16. CASSINOTTI P, BURTONOBOY G, FOPP M, SIEGL G: Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 1997, 53: 229-32.